Is Chemotherapy Being Replaced? What New Immunotherapy Trials Mean for Patients
For decades, chemotherapy has been one of the most common treatments for cancer. While it can be effective, it is also known for its difficult side effects—fatigue, nausea, dehydration, and weakened immunity.
Now, new research is beginning to change that narrative.
Recent clinical trials in colorectal cancer have shown that some patients treated with immunotherapy experienced tumor disappearance or long-term disease control—without needing traditional chemotherapy, surgery, or radiation in the same way as before.
This doesn’t mean chemotherapy is going away entirely. But it does signal a major shift in how cancer may be treated moving forward.
What Is Immunotherapy?
Immunotherapy works differently from chemotherapy.
Chemotherapy attacks rapidly dividing cells, including both cancerous and healthy cells.
Immunotherapy helps the body’s own immune system recognize and attack cancer cells more effectively.
One of the most promising forms is called checkpoint inhibitors, which “release the brakes” on immune cells so they can better fight cancer.
In recent trials, patients with specific genetic markers—such as mismatch repair deficiency (dMMR)—responded especially well to these treatments.
What the New Research Shows
In a recent study:
A significant number of patients saw their tumors shrink or disappear
Many avoided traditional chemotherapy altogether
Some experienced long-term remission with fewer immediate side effects
This is especially important because it suggests that treatment can be tailored to the biology of the cancer, rather than using a one-size-fits-all approach.
Does This Apply to All Cancer Patients?
Not yet.
Immunotherapy is highly effective in certain cancers and specific patient groups, but it is not universal. Its success often depends on:
Genetic markers of the tumor
Cancer type and stage
How the immune system interacts with the cancer
For example, patients with dMMR or MSI-high tumors are currently among the most likely to benefit.
This is why testing and personalized treatment plans are becoming more important than ever.
Benefits of Moving Away from Chemotherapy
For eligible patients, reducing or avoiding chemotherapy could mean:
Fewer severe side effects
Lower risk of long-term organ damage
Improved quality of life during treatment
Less disruption to daily routines
However, it’s important to understand that immunotherapy comes with its own set of challenges.
The New Challenge: Managing Side Effects
Immunotherapy is often described as “less toxic” than chemotherapy, but that doesn’t mean it’s easy.
Instead of traditional chemo-related symptoms, patients may experience:
Fatigue
Inflammation-related symptoms (skin, gut, lungs)
Dehydration from reduced appetite or illness
Electrolyte imbalances
These side effects can still impact daily life and recovery—especially if not addressed early.
Why Hydration Still Matters
Whether a patient is receiving chemotherapy or immunotherapy, hydration remains critical.
Proper hydration can help:
Maintain energy levels
Support immune function
Reduce fatigue
Help the body process treatment more effectively
Caregivers often notice that even mild dehydration can worsen symptoms like weakness, dizziness, and confusion.
Supporting consistent hydration—especially when appetite or fluid intake is low—can make a meaningful difference in how patients feel day to day.
What Patients and Caregivers Should Ask
If you or a loved one is navigating treatment, consider asking your care team:
Is immunotherapy an option for this cancer type?
Should we test for biomarkers like MSI or dMMR?
What side effects should we expect with this treatment?
How can we best manage fatigue and hydration?
These conversations can help clarify whether newer treatment approaches may be appropriate.
A Shift, Not a Replacement
It’s important to be realistic: chemotherapy is still a critical tool in cancer treatment and will remain so for many patients.
But what’s changing is choice.
More patients may soon have options that:
Are more targeted
Better tolerated
Designed specifically for their cancer
This shift toward personalized care is one of the most important developments in oncology today.
Final Thoughts
For patients and caregivers, this moment represents both hope and complexity.
Hope—because treatments are becoming more effective and potentially less burdensome.
Complexity—because understanding options, eligibility, and side effects requires more information than ever before.
Staying informed, asking questions, and supporting the body through treatment—including something as simple but essential as hydration—can help patients navigate this evolving landscape with greater confidence.
Reference
PD-1 Blockade in Mismatch Repair–Deficient, Locally Advanced Rectal Cancer
For more information on how HuMOLYTE can support your gut health during chemotherapy, visit our product page or consult your health care provider.
This blog was reviewed by Dr. Sourabh Kharait.
This blog is for educational purposes only and is not intended as medical advice. Always consult with your healthcare provider before making any changes to your treatment plan, hydration strategies, or diet. The information provided here is based on general insights and may not apply to individual circumstances.
